中医药临床杂志2024,Vol.36Issue(12) :2420-2425.DOI:10.16448/j.cjtcm.2024.1240

Ⅲa期非小细胞肺癌根治术后辅助治疗及中医药作用研究进展

Research Progress on Adjuvant Therapy and Traditional Chinese Medicine Effects after Radical Surgery for Stage Ⅲa Non-small Cell Lung Cancer

毕向雁 刘苓霜
中医药临床杂志2024,Vol.36Issue(12) :2420-2425.DOI:10.16448/j.cjtcm.2024.1240

Ⅲa期非小细胞肺癌根治术后辅助治疗及中医药作用研究进展

Research Progress on Adjuvant Therapy and Traditional Chinese Medicine Effects after Radical Surgery for Stage Ⅲa Non-small Cell Lung Cancer

毕向雁 1刘苓霜1
扫码查看

作者信息

  • 1. 上海中医药大学附属龙华医院 上海 200032
  • 折叠

摘要

非小细胞肺癌(NSCLC)占肺癌的 80%~85%,约 1/3 的患者在最初诊断时已处于局部晚期(Ⅲa期/Ⅲb期),对于可手术切除的Ⅲa期患者,单纯手术后仍具有较高的复发率和死亡率,其 5 年生存率仅为 23%.因此,为预防Ⅲa期NSCLC术后复发转移,辅助治疗越发重要,目前主要治疗方式有化疗、放疗、靶向治疗、免疫治疗等.近年来,中医综合治疗模式的探索有望降低术后复发转移,从而提高肺癌患者生存期.

Abstract

Non small cell lung cancer(NSCLC)accounts for 80%~85%of lung cancer cases,and about one-third of patients are already locally advanced(stage Ⅲa/Ⅲb)at the time of initial diagnosis.For stage Ⅲa patients who can be surgically resected,simple surgery still has a high recurrence and mortality rate,with a 5-year survival rate of only 23%.Therefore,in order to prevent postoperative recurrence and metastasis of stage Ⅲa NSCLC,adjuvant therapy is becoming increasingly important.Currently,the main treatment methods include chemotherapy,radiotherapy,target-ed therapy,immunotherapy,etc.In recent years,the exploration of the comprehensive treatment mode of traditional Chinese medicine is expected to reduce postoperative recurrence and metastasis,thereby improving the survival of lung cancer patient

关键词

Ⅲa期非小细胞肺癌根治术/辅助治疗/中医药治疗

Key words

radical surgery for stage Ⅲa non-small cell lung cancer/Adjuvant therapy/Traditional Chinese Med-icine Treatment

引用本文复制引用

出版年

2024
中医药临床杂志
中华中医药学会

中医药临床杂志

影响因子:0.636
ISSN:1672-7134
段落导航相关论文